本文選題：鹽酸氟桂利嗪　切入點(diǎn)：錐體外系反應(yīng)　出處：《藥物流行病學(xué)雜志》2016年11期 　論文類型：期刊論文

【摘要】：正1臨床資料病例1:男,72歲,2015年4月因頭痛在某院門診就診,查頭顱CT示腦積水,予鹽酸氟桂利嗪膠囊(西比靈,西安楊森制藥有限公司,批號不詳)20 mg qn及阿司匹林腸溶片100mg qd治療,數(shù)天后頭痛緩解,醫(yī)師囑其繼續(xù)服藥�；颊咦孕性谒幍曩徺I持續(xù)服藥,2015年7月漸出現(xiàn)動作緩慢,行走困難,曾在某院門診,考慮"帕金森病"予多巴絲肼片250mg tid
[Abstract]:In April 2015, a 72-year-old male with headache was admitted to an outpatient clinic in a hospital. The head CT showed hydrocephalus and was treated with flunarizine hydrochloride capsule (Sibiline, Xi'an Yang Sen Pharmaceutical Co., Ltd.). Batch number was not known to be 20 mg QN and aspirin enteric-coated tablet 100 mg QD. After a few days of treatment, the headache was relieved, and the doctor told him to continue taking the medicine. The patient bought and continued to take the drug at the drugstore. In July 2015, the patient gradually appeared slow and difficult to walk, and had been in a hospital outpatient clinic. Consider "Parkinson's disease" with dobutazid 250mg tid
【作者單位】： 溫州醫(yī)科大學(xué)附屬第一醫(yī)院神經(jīng)科;樂清人民醫(yī)院康復(fù)科;
【分類號】：R971
，

本文編號：1593537